<?xml version="1.0" encoding="UTF-8"?>
<ref id="B43-pharmaceuticals-12-00101">
 <label>43.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Niu</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Qu</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Yao</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Yan</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Liang</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Luo</surname>
    <given-names>J.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Convalescent patient-derived monoclonal antibodies targeting different epitopes of E protein confer protection against Zika virus in a neonatal mouse model</article-title>
  <source>Emerg. Microbes Infect.</source>
  <year>2019</year>
  <volume>8</volume>
  <fpage>749</fpage>
  <lpage>759</lpage>
  <pub-id pub-id-type="doi">10.1080/22221751.2019.1614885</pub-id>
  <?supplied-pmid 31130109?>
  <pub-id pub-id-type="pmid">31130109</pub-id>
 </element-citation>
</ref>
